Inflammatory responses to psychological stress in fatigued breast cancer survivors: Relationship to glucocorticoids

被引:117
作者
Bower, Julienne E.
Ganz, Patricia A.
Aziz, Najib
Olmstead, Richard
Irwin, Michael R.
Cole, Steve W.
机构
[1] Univ Calif Los Angeles, Semel Inst Neurosci, Cousins Ctr Psychoneuroimmunol, Los Angeles, CA 90095 USA
[2] Univ Calif Los Angeles, David Geffen Sch Med, Dept Psychiat & Biobehav Sci, Los Angeles, CA 90095 USA
[3] Univ Calif Los Angeles, Jonsson Comprehens Canc Ctr, Div Canc Prevent & Control Res, Los Angeles, CA 90095 USA
[4] Univ Calif Los Angeles, Sch Med, Los Angeles, CA 90095 USA
[5] Univ Calif Los Angeles, Sch Publ Hlth, Los Angeles, CA 90095 USA
[6] Univ Calif Los Angeles, Dept Pathol & Lab Med, Los Angeles, CA 90095 USA
[7] Univ Calif Los Angeles, Dept Med, Los Angeles, CA 90095 USA
关键词
breast cancer; fatigue; inflammation; HPA axis; stress; QUALITY-OF-LIFE; ACUTE MENTAL STRESS; PSYCHOSOCIAL STRESS; CYTOKINE PRODUCTION; PERSISTENT FATIGUE; HEMOGLOBIN LEVELS; SENSITIVITY; IMPACT; INTERLEUKIN-6; THERAPY;
D O I
10.1016/j.bbi.2006.08.001
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Fatigue is a common problem following cancer treatment and our previous studies suggest that a chronic inflammatory process might contribute to cancer-related fatigue. However, immune responses to challenge have not yet been evaluated among individuals with cancer-related fatigue, and it is not known what mechanisms drive increased levels of inflammatory markers in fatigued cancer survivors. We have previously reported that fatigued breast cancer survivors show a blunted cortisol response to an experimental psychological stressor. In this report.. we focus on inflammatory responses to this stressor and their relationship to circulating glucocorticoids and cellular sensitivity to glucocorticoid inhibition. Relative to non-fatigued control survivors, participants experiencing persistent fatigue showed significantly greater increases in LPS-stimulated production of IL-1 beta and IL-6 following the stressor (Group x Time interaction: p <.05). Fatigued participants did not show any difference in cellular sensitivity to cortisol inhibition of cytokine production, but they did show significantly less salivary cortisol increase in the aftermath of the stressor. Moreover, blunted cortisol responses were associated with significantly increased production of IL-6 in response to LPS stimulation (p <.05). These data provide further evidence of enhanced inflammatory processes in fatigued breast cancer survivors and suggest that these processes may stem in part from decreased glucocorticoid response to stress. (c) 2006 Elsevier Inc. All rights reserved.
引用
收藏
页码:251 / 258
页数:8
相关论文
共 41 条
[1]   Off-treatment fatigue in breast cancer survivors: A controlled comparison [J].
Andrykowski, MA ;
Curran, SL ;
Lightner, R .
JOURNAL OF BEHAVIORAL MEDICINE, 1998, 21 (01) :1-18
[2]  
[Anonymous], 1875, BDI 2 MANUAL
[3]   Fatigue in long-term breast carcinoma survivors - A longitudinal investigation [J].
Bower, JE ;
Ganz, PA ;
Desmond, KA ;
Bernaards, C ;
Rowland, JH ;
Meyerowitz, BE ;
Belin, TR .
CANCER, 2006, 106 (04) :751-758
[4]   Altered cortisol response to psychologic stress in breast cancer survivors with persistent fatigue [J].
Bower, JE ;
Ganz, PA ;
Aziz, N .
PSYCHOSOMATIC MEDICINE, 2005, 67 (02) :277-280
[5]   Diurnal cortisol rhythm and fatigue in breast cancer survivors [J].
Bower, JE ;
Ganz, PA ;
Dickerson, SS ;
Petersen, L ;
Aziz, M ;
Fahey, JL .
PSYCHONEUROENDOCRINOLOGY, 2005, 30 (01) :92-100
[6]   T-cell homeostasis in breast cancer survivors with persistent fatigue [J].
Bower, JE ;
Ganz, PA ;
Aiziz, N ;
Fahey, JL ;
Cole, SW .
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2003, 95 (15) :1165-1168
[7]   Fatigue and proinflammatory cytokine activity in breast cancer survivors [J].
Bower, JE ;
Ganz, PA ;
Aziz, N ;
Fahey, JL .
PSYCHOSOMATIC MEDICINE, 2002, 64 (04) :604-611
[8]   Fatigue in breast cancer survivors: Occurrence, correlates, and impact on quality of life [J].
Bower, JE ;
Ganz, PA ;
Desmond, KA ;
Rowland, JH ;
Meyerowitz, BE ;
Belin, TR .
JOURNAL OF CLINICAL ONCOLOGY, 2000, 18 (04) :743-753
[9]   Early depressive symptoms in cancer patients receiving interleukin 2 and/or interferon alfa-2b therapy [J].
Capuron, L ;
Ravaud, A ;
Dantzer, R .
JOURNAL OF CLINICAL ONCOLOGY, 2000, 18 (10) :2143-2151
[10]   Cancer-related fatigue: Prevalence of proposed diagnostic criteria in a United States sample of cancer survivors [J].
Cella, D ;
Davis, K ;
Breitbart, W ;
Curt, G .
JOURNAL OF CLINICAL ONCOLOGY, 2001, 19 (14) :3385-3391